Publications

Results of a Randomized Phase Ii Trial of Paclitaxel and Carboplatin Versus Bleomycin, Etoposide and Cisplatin for Newly Diagnosed and Recurrent Chemonaive Stromal Ovarian Tumors: An Nrg Oncology/Gynecologic Oncology Group Study14

AuthID
P-017-C8K

Author(s)

Brown J.

Miller A.

Holman L.L.

Backes F.

Nagel C.

Bender D.

Miller D.S.

Powell M.A.

Westin S.N.

Bonebrake A.

Muller C.Y.

Secord A.A.

Crane E.

Schorge J.

Tew W.P.

Sood A.K.

Bookman M.A.

Aghajanian C.

Gershenson D.M.

Document Type

Article

Year published

2024

Published

in Gynecologic Oncology, ISSN: 00908258

Volume: 190, Pages: 283-290 (7)

Indexing

Scopus^®

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.ygyno.2024.09.002

Scopus: 2-s2.0-85203496857

Source Identifiers

ISSN: 00908258

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Results of a Randomized Phase Ii Trial of Paclitaxel and Carboplatin Versus Bleomycin, Etoposide and Cisplatin for Newly Diagnosed and Recurrent Chemonaive Stromal Ovarian Tumors: An Nrg Oncology/Gynecologic Oncology Group Study14

Useful Links

Get Help

Federated Authentication (Click on the image)

Results of a Randomized Phase Ii Trial of Paclitaxel and Carboplatin Versus Bleomycin, Etoposide and Cisplatin for Newly Diagnosed and Recurrent Chemonaive Stromal Ovarian Tumors: An Nrg Oncology/Gynecologic Oncology Group Study14

Useful Links

Get Help